A method for the therapeutic or prophylactic treatment of a disease, the method comprising the steps of:
- administering to a patient in need thereof a therapeutically or prophylactically effective amount of Translocase of Outer Membrane 6 kDa subunit homolog (TOMM6)-interacting compound or a composition comprising the same, wherein the TOMM6-interacting compound is a compound according to Formula (II):
- wherein:
- R2 to R6 are each independently selected from the group consisting of
- (i) H, Cl, Br, F, —CN, or —OH,
- (ii) —O(C1-10)alkyl or —O(C3-10)cycloalkyl,
- (iii) —O(C═O)(C1-10)alkyl, or —O(C═O)(C3-10)cycloalkyl,
- (iv) —COOH, —COO(C1-10)alkyl, —COO(C3-6)cycloalkyl, —COONH2, —COON((C1-10)alkyl)2, or —COONH(C1-10)alkyl,
- R7 is selected from the group consisting of:
- (i) NH2, NH(C1-10)alkyl, —OH, —O(C1-10)alkyl, or —CN;
- (ii) —COOH, —COO(C1-10)alkyl, —COO(C3-6)cycloalkyl, —COONH2, —COON((C1-10)alkyl)2, or —COONH(C1-10)alkyl;
- (iii) substituted or non-substituted carbocycle selected from the group consisting of (C3-10)carbocycle;
- and
- (iv) substituted or non-substituted (C3-6)heterocycle or (C7-10)carbo- or hetero-bicycle having 1 to 3 heteroatoms each independently selected from N, O and S;
- R8 is selected from the group consisting of —C(═O)NH2, —CN (instead of R8—CO), —C(═O)NH(C1-10)alkyl, —C(═O)OH, or —C(═O)O(C1-10)alkyl;
- R9 is selected from the group consisting of:
- (i) —H, -Me, -Et, halogen;
- (ii) —COOH, —COO(C1-10)alkyl, —COO(C3-6)cycloalkyl, —COONH2, —COON((C1-10)alkyl)2, or —COONH(C1-10)alkyl;
- (iii) —OH, —O(C1-10)alkyl, or —O(C3-10)cycloalkyl;
- (iv) substituted or non-substituted (C3-10)carbocycle,;
- and
- c is an integer between 0 and 4;
- and pharmaceutically acceptable salts and solvates thereof,
- wherein the disease is selected from the group consisting of:
- (a) a nervous system disease or disorder;
- (b) atherosclerosis;
- (c) Hepatitis B infection;
- and
- (d) human papilloma virus (HPV) infection.